For Australian businesses experiencing supply chain volatility and disruptions, visit the Go Global Toolkit for the latest updates and support available.
Successive shockwaves have hit Australian trade in the last 6 years. With disruption here to stay, diversification is core to building resilience.
Three key events have overturned the stable trading environment of the 2010s.
‘These events mean we are living in a new world,’ says Jay Meek, General Manager, Trade Diversification Taskforce, Austrade. ‘We are a natural exporting country. The government has a clear policy to support trade diversification.’
In 2025, the Australian Government launched the $55 million Accessing New Markets Initiative (ANMI).
‘ANMI was set up to bring government and industry closer together and help Australian companies adjust to a fast-changing world,’ says Meek.
Peak industry bodies play a crucial role supporting diversification.
The Trade Diversification Network (TDN) consists of 40 national peak industry bodies. The TDN works with government to ensure ANMI support is aligned with the needs of their members.
According to Stuart Charity, Chief Executive Officer, Australian Aftermarket Automotive Association (AAAA), the TDN comes at a critical time.
‘It’s not just about building customers overseas, it’s about not putting everything in one market,’ he says.
‘If you are reliant on one, big overseas market, you are vulnerable – and not just to peaks and troughs. Sometimes, customer bases just change, and that’s not in your control.
‘Diversification is about spreading risk.’
‘There are pockets of genius in Australia. Small companies can create global competitive advantage without knowing it.’
Stuart Charity, Chief Executive Officer, AAAA
Rebekah Cassidy, Chief Executive Officer of AusBiotech, says the speed of global change impacting biotech has accelerated over recent years.
‘The biotech world is changing fast,’ she says. ‘Countries are looking to on-shore a range of capabilities from clinical trials to advanced manufacturing.
‘As different countries build out their biotech strategies they are employing a range of business incentives to attract capabilities. For our members that can mean new opportunities and also new competition.
‘We have been working closely with Austrade on a range of measures to help Australia’s biotech, medtech and health tech innovators navigate this changing environment.
'Our shared goals include keeping and attracting more clinical trials in Australia, helping Australian innovators navigate new markets, and ensure Australia’s wide ranging health innovation capabilities are on show across globally.'
According to Charity, AAAA members provide some great examples of how diversification can save an industry.
Many of his members faced ruin when Australia’s car-manufacturing industry shut down. Today, many have built businesses around new activities, for example, in customisation and recreational vehicles. These capabilities have export potential.
‘There are pockets of genius in Australia,’ says Charity. ‘Small companies can create global competitive advantage without knowing it.’
Charity lists three reasons why small Australian businesses can be globally competitive:
‘Some great ideas will only ever find a small market in Australia,’ says Charity. ‘By going overseas, you build volume.
‘Some of our members began their businesses in their garages. Now they have a global reputation.’
Since Covid, the Australian Government has worked hard to give local companies a competitive advantage in overseas markets. This creates fresh opportunities for diversification.
‘The Government has made a concerted effort to forge free trade agreements (FTAs) with regions that have major growth opportunities,’ says Meek. ‘Most recently, these FTAs include India and the UAE.’
Australia was the first developed economy to sign a comprehensive trade agreement with India. This gives Australian brands a head start in a vast market that is developing fast.
‘In India, we can capitalise on our reputation as a supplier of good quality products,’ says Meek. ‘There are challenges to be sure, but huge opportunities over time.
‘Soon we will have an FTA in force with the European Union. That means easier access to 27 markets.’
‘Be curious. Work with industry and contacts to find opportunities, including markets and sectors you haven’t previously considered.’
Jay Meek, General Manager, Trade Diversification Taskforce, Austrade
For biotech, Cassidy says engaging early and understanding your future markets is key.
“Biotech is a global business. Austrade understands that and has been working closely with AusBiotech over recent years to ensure Australian innovators and services providers, including clinical research organisations and manufacturers, have multiple points of engagement.”
“One of our messages is to engage and build your understanding of the support that’s available early.”
Charity makes the point that exporters are finding new pathways to overseas customers.
‘Our members are starting to go to consumer shows,’ he says. ‘They are bypassing the B2B export model and going straight to the end customer. This was impossible 15 years ago.’
‘Engage and build your understanding of the support that’s available early.’
Rebekah Cassidy, Chief Executive Officer, AusBiotech
Under ANMI, industry and government are working closely to promote global opportunities.
‘I’d encourage companies to work with industry bodies on the best approach to diversify markets,’ says Meek.
Exporters can also leverage the full range of Austrade services.
Meek recommends several practical steps for companies that want to start on a diversification journey:
Charity’s top tip is to attend trade shows and prepare in advance.
‘Pre-connect,’ he says. ‘Set up meetings in advance. And don’t select the first distributor who shows interest. Shop around.’
Cassidy says that in biotech, market information is key.
‘Make sure your market research is as rigorous as you can make it,’ she says. ‘Get a thorough knowledge of access pathways. Take advantage of tools that can help you – like the Go Global Toolkit.
‘Most importantly: speak with the Austrade team including AusBiotech’s Head of Global Trade & Partnerships who is part of a joint initiative under the Trade Start program – to help get the full benefit of available in-market expertise.
‘There are plenty of market experts you can access via the TDN and Austrade. These are great resources – use them.’
Austrade’s Go Global Toolkit helps you learn the export basics, find the right markets and understand market requirements.